Condensed Consolidated Statements of Operations and Comprehensive Loss (Statement) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 22,534	$ 18,876
Total cost of revenue	23,964	18,782
Gross profit (loss)	(1,430)	94
Operating expenses:
Research and development	8,628	7,870
Selling and marketing	7,991	6,884
General and administrative	11,582	12,814
Total operating expenses	28,201	27,568
Loss from operations	(29,631)	(27,474)
Interest income	1,341	5
Interest expense	(2,626)	(1,064)
Other (expense) income, net	2,057	2,759
Loss before provision for income taxes	(28,859)	(25,774)
Provision for income taxes	0	0
Net loss and comprehensive loss	$ (28,859)	$ (25,774)
Net loss per share, basic (in USD per share)	$ (0.16)	$ (0.14)
Net loss per share, diluted (in USD per share)	$ (0.16)	$ (0.14)
Weighted-average common shares used to compute net loss per share attributable to common stockholders, basic (in shares)	182,310,900	179,740,732
Weighted-average common shares used to compute net loss per share attributable to common stockholders, diluted (in shares)	182,310,900	179,740,732
Product
Total revenue	$ 15,782	$ 13,426
Total cost of revenue	16,939	13,766
Service
Total revenue	6,519	5,331
Total cost of revenue	7,025	5,016
Distribution rights
Total revenue	$ 233	$ 119